← All organizations
Timeline
1980s
- Jun 1, 1984
Advent International— Founded
2020s
- Sep 8, 2021
Swedish Orphan Biovitrum— Acquired
Drugs by trial phase (93 distinct, 184 trials)
Phase 4 (0 own, 6 via acquisition)
Phase 3 (0 own, 28 via acquisition)
- ibritumomab tiuxetan
- coagulation factor ix (Recombinant)
- prednisone
- antihemophilic factor viii (Recombinant), Fc-fusion protein
- gemcitabine
- paclitaxel
- nitisinone
- vincristine
- pixuvri
- ifosfamide
- carboplatin
- coagulation factor ix (Recombinant), Fc-fusion protein
- bile-salt-stimulated lipase
- immune globulin (human)
- cyclophosphamide
- +13 more
Phase 2 (0 own, 46 via acquisition)
Phase 1 (0 own, 13 via acquisition)
Subsidiaries (1 direct, 10 total across the full acquisition tree)
Details
- Founded
- Boston, MA, US Jun 1, 1984
Notes
Investment bankers